Effect of Leish G1 cream in leishmaniasis
Phase 3
Recruiting
- Conditions
- Cutaneous Leishmaniasis.Cutaneous leishmaniasis
- Registration Number
- IRCT20180115038383N1
- Lead Sponsor
- Shahed University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with Cutaneous leishmaniasis approved by direct examinations
Up to 5 lesions in each patient
Duration of disease up to 3 months
Patients who have not used anti leishmaniasis therapies
Exclusion Criteria
Patients with facial lesions
Patients with Lymphangitis lesions
Patients with Immunodeficiency disorders
Patients who use immunosuppressive drugs
Patients with other skin diseases such as Eczema, Psoriasis and Lupus
Patients with severe mental disorders such as Major Depressive Disorder and Psychosis
Concomitant use of other medications
Pregnancy or lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wound healing. Timepoint: Evaluating size and grade of cutaneous lesion in days 0, 14, 28 and 60 aftertreatment. Method of measurement: Ruler.
- Secondary Outcome Measures
Name Time Method